Processa Pharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: PCSA · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1533743
| Field | Detail |
|---|---|
| Company | Processa Pharmaceuticals, Inc. (PCSA) |
| Form Type | 8-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, 8-k
TL;DR
Processa Pharma filed an 8-K for a shareholder vote on 7/15/25. Details TBD.
AI Summary
Processa Pharmaceuticals, Inc. filed an 8-K on July 15, 2025, reporting on matters submitted to a vote of its security holders. The filing does not contain specific details about the vote outcomes or the proposals presented, but it confirms the company's ongoing compliance and reporting obligations.
Why It Matters
This filing indicates that Processa Pharmaceuticals held a shareholder vote, which is a standard corporate governance event. The details of the vote are crucial for understanding shareholder sentiment and the direction of the company.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Processa Pharmaceuticals, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 45-1539785 (ein) — I.R.S. Employer Identification Number
- 001-39531 (commission_file_number) — Commission file number
FAQ
What specific matters were submitted to a vote of Processa Pharmaceuticals' security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals or resolutions voted upon.
When was the report filed and what is the earliest event date reported?
The report was filed on July 15, 2025, and the earliest event date reported is also July 15, 2025.
What is Processa Pharmaceuticals' principal executive office address?
The principal executive offices are located at 601 21st Street, Suite 300, Vero Beach, FL 32960.
What is the company's telephone number?
The registrant's telephone number is (772) 453-2899.
What was Processa Pharmaceuticals' former company name?
The former company name was Heatwurx, Inc., with a date of name change on October 28, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding Processa Pharmaceuticals, Inc. (PCSA).